Lloyds, Stan Chart weigh on FTSE 100 amid global stocks rout; AstraZeneca gains

(Reuters) - Gloomy quarterly results from banks and a clutch of other firms saw the FTSE 100 post its worst session in five weeks on Thursday, while uncertainty about U.S. elections and a collapse in economic growth in the world’s largest economy also weighed.

FILE PHOTO: Signage is seen outside the entrance of the London Stock Exchange in London, Britain. Aug 23, 2018. REUTERS/Peter Nicholls/File Photo

Global sentiment took a hit as a 32.9% plunge in U.S. second quarter economic growth, albeit lesser than expected, and a tweet from U.S. President Donald Trump about possibly delaying November elections unnerved markets.

“There’s already heightened uncertainty around the election ... and the potential for a fiscal policy regime change. This just adds to that uncertainty,” said Phil Orlando, chief equity market strategist, at Federated Hermes in New York.

The blue-chip FTSE 100 .FTSE ended 2.3% lower on broad-based losses, with Lloyds Banking Group LLOY.L sliding 7.6% to an eight-year low after swinging to a rare pre-tax loss in the first half of 2020.

Standard Chartered STAN.L tumbled 6.2% as the lender posted a 33% slump in first-half profit after a six-fold jump in credit impairment charges.

The mid-cap FTSE 250 .FTMC slipped 1.3%, led by a 12% fall for car dealer Inchcape INCH.L as impairment charges pushed it to losses.

The export-laden FTSE 100 is on track to record monthly declines in July after rallying since April as faltering economic data and surging COVID-19 cases have dented optimism over a swift post-pandemic economic recovery.

Oil majors .FTNMX0530 BP BP.L and Royal Dutch Shell RDSa.L lost 3.6% and 5.5% as crude prices fell on fears that more COVID-19 containment measures could hurt demand. [O/R]

London shares of travel company TUI TUIT.L slipped after it said it will shut 166 stores in the UK and Ireland due to the downturn in travel caused by the coronavirus - a move that will lead to more losses in the battered sector.

AstraZeneca AZN.L, meanwhile, rose 1.6% on an upbeat second quarter and reiteration of 2020 forecasts, while defence company BAE Systems BAES.L jumped after announcing plans to restart dividend payouts.

Additional reporting by Sinead Carew in New York; Editing by Uttaresh.V and Sherry Jacob-Phillips